SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000914121-20-003620
Filing Date
2020-10-07
Accepted
2020-10-07 10:46:38
Documents
3
Group Members
SACHEM HEAD GP LLCSCOTT D. FERGUSONUNCAS GP LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sa55321029-sc13d_elanco.htm SC 13D 124305
2 JOINT FILING AGREEMENT sa55321029-ex99_1.htm EX-99.1 11956
3 TRADING DATA sa55321029-ex99_2.htm EX-99.2 21376
  Complete submission text file 0000914121-20-003620.txt   159190
Mailing Address 250 WEST 55TH STREET 34TH FLOOR NEW YORK NY 10019
Business Address 250 WEST 55TH STREET 34TH FLOOR NEW YORK NY 10019 212-714-3300
Sachem Head Capital Management LP (Filed by) CIK: 0001582090 (see all company filings)

IRS No.: 800872416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Subject) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90921 | Film No.: 201228324
SIC: 2834 Pharmaceutical Preparations